Fluid Biomed Inc. Raises $27 Million USD in Oversubscribed Series A Financing to Advance World’s First Bioabsorbable Polymer-Based Stent To Treat Brain Aneurysms
/
DateDec 16 2024
Funding co-led by Amplitude Ventures and an undisclosed major strategic investor to advance the ReSolv™ stent into additional human clinical trials CALGARY, Alberta–(BUSINESS WIRE)–Fluid Biomed... Read More →